Liraglutide
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Novo Nordisk · Phase 3 · Completed · Enrollment 359
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Liraglutide 3.0 mg | 47 participants | 13 participants | 29 participants | n/r | n/r |
| Placebo | 12 participants | 5 participants | 14 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.